| # | Drug | Count |
|---|---|---|
| 0 | LEVONORGESTREL | 30 |
| 1 | COPPER | 20 |
| 2 | ADALIMUMAB | 4 |
| 3 | CITALOPRAM | 3 |
| 4 | ETONOGESTREL AND ETHINYL ESTRADIOL | 3 |
| 5 | CITALOPRAM HYDROBROMIDE | 2 |
| 6 | HYDROCHLOROTHIAZIDE | 2 |
| 7 | HYDROXYZINE PAMOATE | 2 |
| 8 | IBUPFROFEN | 2 |
| 9 | IBUPROFEN | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROXYZINE PAMOATE | 2 | 0.0005 |
| 1 | COPPER | 20 | 0.0005 |
| 2 | OXYTOCIN | 1 | 0.0003 |
| 3 | LISDEXAMFETAMINE DIMESYLATE CAPSULES | 1 | 0.0002 |
| 4 | LEVONORGESTREL | 30 | 0.0001 |
| 5 | ETONOGESTREL AND ETHINYL ESTRADIOL | 3 | 0.0001 |
| 6 | OXCARBAZEPINE | 2 | 0.0001 |
| 7 | FOSCARBIDOPA/FOSLEVODOPA | 1 | 0.0001 |
| 8 | TESTOSTERONE CYPIONATE | 1 | 0.0001 |
| 9 | TESTOSTERONE | 2 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 33 |
| 1 | Progestin-containing Intrauterine System [EPC] | 30 |
| 2 | Copper-containing Intrauterine Device [EPC] | 20 |
| 3 | Estrogen [EPC] | 3 |
| 4 | Androgen [EPC] | 2 |
| 5 | Anti-epileptic Agent [EPC] | 2 |
| 6 | Benzodiazepine [EPC] | 2 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 |
| 8 | Serotonin Reuptake Inhibitor [EPC] | 2 |
| 9 | Thiazide Diuretic [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Copper-containing Intrauterine Device [EPC] | 20 | 0.0004 |
| 1 | Oxytocic [EPC] | 1 | 0.0003 |
| 2 | Progestin [EPC] | 33 | 0.0001 |
| 3 | Androgen [EPC] | 2 | 0.0001 |
| 4 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 5 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 6 | Serotonin Reuptake Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Estrogen [EPC] | 3 | 0.0000 |
| 8 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Central Nervous System Stimulant [EPC] | 1 | 0.0000 |